Compounds > oxycodone

oxycodone and Sclerosis, Systemic

oxycodone has been researched along with Sclerosis, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Abignano, G; Lettieri, G; Mennillo, GA1
Crotti, C; Ingegnoli, F; Ughi, N1

Other Studies

2 other study(ies) available for oxycodone and Sclerosis, Systemic

ArticleYear
Foot ulcers in systemic sclerosis escape surgical amputation.
    Lancet (London, England), 2020, 09-12, Volume: 396, Issue:10253

    Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Foot Ulcer; Humans; Iloprost; Naloxone; Nifedipine; Oxycodone; Rivaroxaban; Scleroderma, Systemic; Vasodilator Agents

2020
Effectiveness and safety of oxycodone/naloxone in the management of chronic pain in patients with systemic sclerosis with recurrent digital ulcers: two case reports.
    Clinical interventions in aging, 2016, Volume: 11

    Topics: Administration, Oral; Aged; Analgesics, Opioid; Chronic Pain; Drug Therapy, Combination; Female; Fingers; Humans; Middle Aged; Naloxone; Oxycodone; Pain Management; Quality of Life; Scleroderma, Systemic; Skin Ulcer; Wound Healing

2016